Medite Cancer Diagnostics, Inc. (MDIT)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2017 2016 2015
Revenue 6.81 Million 9.23 Million 9.88 Million
Cost of Revenue 6.94 Million 5.82 Million 6.26 Million
Gross Profit -131 Thousand 3.41 Million 3.62 Million
Operating Expenses 6.34 Million 5.07 Million 4.22 Million
Selling, General and Administrative Expenses 5.16 Million 3.6 Million 2.94 Million
Research and Development Expenses 1.18 Million 1.47 Million 1.27 Million
Other Expenses - - -
Cost and Expenses 13.29 Million 10.89 Million 10.48 Million
Operating Income -6.48 Million -1.66 Million -599 Thousand
Interest Expense 849 Thousand 694 Thousand 204 Thousand
Income Tax Expense -487 Thousand -132 Thousand 78 Thousand
Earnings before Tax -7.29 Million -2.29 Million -781 Thousand
Net Income -6.81 Million -2.16 Million -859 Thousand
Earnings Per Share Basic -0.26 -0.10 -0.04
Earnings Per Share Diluted -0.26 -0.10 -0.04
Weighted Average Shares Outstanding 26.43 Million 21.42 Million 20.19 Million
Weighted Average Shares Outstanding (Diluted) 26.43 Million 21.42 Million 20.19 Million
Gross Margin -0.02 0.37 0.37
EBIT Margin -0.91 -0.16 -0.04
Profit Margin -1.00 -0.23 -0.09
EBITDA -6.18 Million -1.44 Million -422 Thousand
Earnings Before Tax Margin -0.95 -0.18 -0.06

Income Statement Charts